Databeacon Cures Sales Reporting Ailments for the Harvard Drug Group

Published August 24, 2004

Databeacon Inc., a developer of Web reporting and data analysis software, announced it has been selected by the Harvard Drug Group, a secondary brand wholesaler and generic drug and consumer products distributor, to provide robust sales reporting and data analysis capabilities. This win is a result of Databeacon partner Subject, Wills & Company. To date, the Databeacon implementation has already helped the Harvard Drug Group significantly reduce the time needed to develop daily and month-end sales and management reports.

With three products lines and three operating warehouses located across the country, the Harvard Drug Group needed to replace its outdated system, which provided limited data access and could not meet the company's growing demands. The Harvard Drug Group chose Databeacon software for its ease of use, Web-based functionality and affordable licensing structure.

Now, instead of spending numerous hours to manually input data, the management team can develop daily sales reports in under 30 minutes and monthly reports within an hour. Additionally, using Databeacon software, the Harvard Drug Group has reduced an estimated 700 plus hours of manual data entry per year, enabling employees to focus on more strategic activities.

The features of Databeacon software include ease of use, fast deployment, implementation speed and low cost of ownership and are designed for mid-market organizations like the Harvard Drug Group, whose needs are not met by the often complex and expensive products offered by many of its competitors.